Abstract
Objective and ApproachDirect potable reuse (DPR) involves adding purified wastewater that has not passed through an environmental buffer into a water distribution system. This technology may address growing demand for water in many population centers, but there are no studies of health outcomes in populations receiving DPR-treated drinking water. Our objective was to determine whether the prevalence of congenital anomalies increased in the period following introduction of DPR-treated water to certain public water systems in Texas. We obtained data on all cases with congenital anomalies regardless of pregnancy outcome during 2003-2017 from the population-based Texas Birth Defects Registry. Maternal demographic and residential data were obtained and a reference population of all livebirths in Texas was identified by linkage to birth and fetal death records. The augmented synthetic control method was used to model county-level changes in prevalence of congenital anomalies (expressed per 10,000 livebirths) after the adoption of DPR by four Texas counties in mid-2013. County-level data on maternal age, education, ethnicity, and rural-urban status were included as covariates. Results: We observed increased prevalence of all congenital anomalies collectively (average treatment effect in the treated [ATT] = 53.6) and congenital heart disease (ATT = 287.3) during the years 2014-2017. Neural tube defects prevalence was unchanged. ConclusionsWe found evidence that the prevalence of congenital anomalies overall and congenital heart disease specifically increased during the years 2014-2017. ImplicationsAdditional research into reproductive and developmental outcomes among people in areas supplied with DPR-treated water is warranted to inform water policy decisions.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have